These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 7612899)

  • 1. Aberrant function of the Ras signal transduction pathway in human breast cancer.
    Clark GJ; Der CJ
    Breast Cancer Res Treat; 1995 Jul; 35(1):133-44. PubMed ID: 7612899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Ras signal transduction pathway.
    Khosravi-Far R; Der CJ
    Cancer Metastasis Rev; 1994 Mar; 13(1):67-89. PubMed ID: 8143346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of EGFR and EGFR-downstream pathways in triple negative breast carcinomas with basal like features.
    Martin V; Botta F; Zanellato E; Molinari F; Crippa S; Mazzucchelli L; Frattini M
    Histol Histopathol; 2012 Jun; 27(6):785-92. PubMed ID: 22473698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ISGylation governs the oncogenic function of Ki-Ras in breast cancer.
    Burks J; Reed RE; Desai SD
    Oncogene; 2014 Feb; 33(6):794-803. PubMed ID: 23318454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of the Ras-related TC21/R-Ras2 protein may contribute to the development of human breast cancers.
    Clark GJ; Kinch MS; Gilmer TM; Burridge K; Der CJ
    Oncogene; 1996 Jan; 12(1):169-76. PubMed ID: 8552388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
    McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
    Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ras-induced modulation of CXCL10 and its receptor splice variant CXCR3-B in MDA-MB-435 and MCF-7 cells: relevance for the development of human breast cancer.
    Datta D; Flaxenburg JA; Laxmanan S; Geehan C; Grimm M; Waaga-Gasser AM; Briscoe DM; Pal S
    Cancer Res; 2006 Oct; 66(19):9509-18. PubMed ID: 17018607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving Prospects for Targeting RAS.
    Singh H; Longo DL; Chabner BA
    J Clin Oncol; 2015 Nov; 33(31):3650-9. PubMed ID: 26371146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PIK3CA cooperates with other phosphatidylinositol 3'-kinase pathway mutations to effect oncogenic transformation.
    Oda K; Okada J; Timmerman L; Rodriguez-Viciana P; Stokoe D; Shoji K; Taketani Y; Kuramoto H; Knight ZA; Shokat KM; McCormick F
    Cancer Res; 2008 Oct; 68(19):8127-36. PubMed ID: 18829572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal Growth Factor Receptor Signaling to the Mitogen Activated Protein Kinase Pathway Bypasses Ras in Pancreatic Cancer Cells.
    Lee S; Heinrich EL; Lu J; Lee W; Choi AH; Luu C; Chung V; Fakih M; Kim J
    Pancreas; 2016 Feb; 45(2):286-92. PubMed ID: 26262587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing complexity of Ras signaling.
    Campbell SL; Khosravi-Far R; Rossman KL; Clark GJ; Der CJ
    Oncogene; 1998 Sep; 17(11 Reviews):1395-413. PubMed ID: 9779987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of Ras activation in human breast cancer cell signaling, invasion, and anoikis.
    Eckert LB; Repasky GA; Ulkü AS; McFall A; Zhou H; Sartor CI; Der CJ
    Cancer Res; 2004 Jul; 64(13):4585-92. PubMed ID: 15231670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of forced expression of mutated K-RAS gene on gastrointestinal cancer cell lines and the IGF-1R targeting therapy.
    Matsunaga Y; Adachi Y; Sasaki Y; Koide H; Motoya M; Nosho K; Takagi H; Yamamoto H; Sasaki S; Arimura Y; Tokino T; Carbone DP; Imai K; Shinomura Y
    Mol Carcinog; 2017 Feb; 56(2):515-526. PubMed ID: 27312358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ras proteins as therapeutic targets.
    Chakraborty A; Linnane E; Ross S
    Biochem Soc Trans; 2018 Oct; 46(5):1303-1311. PubMed ID: 30154091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p21Ras downstream effectors are increased in activity or expression in mouse liver tumors but do not differ between ras-mutated and ras-wild-type lesions.
    Kalkuhl A; Troppmair J; Buchmann A; Stinchcombe S; Buenemann CL; Rapp UR; Kaestner K; Schwarz M
    Hepatology; 1998 Apr; 27(4):1081-8. PubMed ID: 9537449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.
    Moon BS; Jeong WJ; Park J; Kim TI; Min do S; Choi KY
    J Natl Cancer Inst; 2014 Feb; 106(2):djt373. PubMed ID: 24491301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of tyrosine kinase inhibitors on the proliferation of human breast cancer cell lines and proteins important in the ras signaling pathway.
    Clark JW; Santos-Moore A; Stevenson LE; Frackelton AR
    Int J Cancer; 1996 Jan; 65(2):186-91. PubMed ID: 8567115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of mutant Ras proteins on the cell signalome.
    Takács T; Kudlik G; Kurilla A; Szeder B; Buday L; Vas V
    Cancer Metastasis Rev; 2020 Dec; 39(4):1051-1065. PubMed ID: 32648136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recapitulation of ras oncogene mutations in breast cancer.
    Stamatakos M; Stefanaki C; Kontzoglou K; Masouridi S; Sakorafas G; Safioleas M
    Onkologie; 2010; 33(10):540-4. PubMed ID: 20926903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of H-Ras-specific motif for the activation of invasive signaling program in human breast epithelial cells.
    Yong HY; Hwang JS; Son H; Park HI; Oh ES; Kim HH; Kim DK; Choi WS; Lee BJ; Kim HR; Moon A
    Neoplasia; 2011 Feb; 13(2):98-107. PubMed ID: 21403836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.